Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|17|19|1874-1889
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.17, Iss.19, 2011-06, pp. : 1874-1889
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Urokinase Receptor and Integrin Interactions
Current Pharmaceutical Design, Vol. 9, Iss. 19, 2003-01 ,pp. :
Access to resources
Recommend
The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. :
The Urokinase Receptor in Hematopoietic Stem Cells Mobilization
Current Pharmaceutical Design, Vol. 17, Iss. 19, 2011-06 ,pp. :
Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design, Vol. 17, Iss. 19, 2011-06 ,pp. :